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Abstract 
 
Nanoparticle-loaded topical formulations can disrupt drug aggregation through controlled 
drug-nanoparticle interactions to enhance topical drug delivery. However, the complex 
relationship between the drug, nanoparticle and formulation vehicle requires further 
understanding. The aim of this study was to use nanoparticle-loaded hydroxypropyl 
methylcellulose (HPMC) and xanthan gum gels to probe how the drug, nanoparticle and 
formulation vehicle interactions influenced the delivery of an aggregated drug into the 
skin. Tetracaine was chosen as a model drug. It was loaded into HPMC and xanthan gum 
gels, and was presented to porcine skin using infinite and finite dosing protocols. Gel 
infinite doses showed no important differences in tetracaine skin permeation rate, but 
HPMC gel finite doses delivered the drug more efficiently (46.99 ± 7.96 µg/cm2/h) 
compared to the xanthan gum (1.16 ± 0.14 µg/cm2/h). Finite doses of the nanoparticle-
loaded HPMC gel generated a 10-fold increase in drug flux (109.95 ± 28.63 µg/cm2/h) 
compared to the equivalent xanthan gum system (14.19 ± 2.27 µg/cm2/h). Rheology 
measurements suggested that the differences in the gels ability to administer the drug into 
the skin were not a consequence of gel-nanoparticle interactions rather they were a 
consequence of the dehydration induced diffusional restriction imparted on the drug by 
xanthan gum compared to the viscosity independent interactions of HPMC with the drug.  
 
Key words: Tetracaine, nanoparticles, skin, aggregation, gel, skin, permeation, HPMC, 
xanthan gum.  
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Introduction 
 
When a drug aggregates it exhibits different physiochemical properties in solution 
compared to the non-aggregated form of the molecule [1-4]. Therefore, at high drug 
concentrations, i.e., those above the critical aggregation concentration, it can be the 
properties of aggregates that determine a drug’s behaviour rather than the individual 
molecules from which the aggregates are generated. The process of physical aggregation 
can hinder drug delivery into the skin after topical application, but it is not traditionally 
investigated during topical formulation development [5, 6]. Physical drug aggregation 
that occurs on the surface of the skin, is reversible at lower drug concentrations [5]. 
However, using low drug concentrations is not an effective solution to combat the 
problems associated with drug aggregation in topical formulations, as reducing the drug 
concentration applied to the skin can also reduce the clinical response to the preparation 
[5].  
 
Nanomaterials can break up drug aggregation even at high drug concentrations 
through surface interactions that make the drug more available for permeation [7-10]. 
When nanoparticles act to break up aggregation, rather than acting as a drug carrier, they 
act on the skin surface, within the topical formulation, as a chemical penetration enhancer 
[11]. If the nanomaterials are 50 nm or larger they are unlikely to enter the body and 
therefore this approach raises very few additional toxicity concerns [12-14]. However, 
presenting a drug-nanoparticle combination to the surface of the skin presents a challenge 
because semi-solid formulation excipients can interact with both the drug and the 
nanoparticles [15]. If the drug-nanoparticle equilibrium is disrupted, this may have 
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deleterious effects on the nanoparticle penetration enhancement effects when 
administered to the skin [11]. Therefore, more information is required with regards to the 
drug-nanoparticle-delivery vehicle interactions in topical formulations that attempt to 
administer and aggregated drug into the skin.  
 
A topical gel is a one-phase system and therefore represents the simplest vehicle 
in which a drug can be applied to the skin. However, the gelling agent and the solvent 
that are combined to generate a gel do interact with the drug in order to solubilise it. 
Through these interactions the topical vehicle controls the drug’s thermodynamic activity 
[16], it influences the drug’s diffusion coefficient towards its site of absorption [17, 18] 
and it interacts with the skin barrier upon which it is deposited during the delivery 
process [19, 20]. Therefore, a complex relationship between the gel formulation factors 
and delivery usually exists. This complexity is increased when attempting to administer 
both an aggregated drug and a nanoparticle to the skin because the drug concentration 
will influence its aggregation state and the drug’s thermodynamic activity, the gelling 
agent concentration will influence the vehicle viscosity and aesthetic characteristics of the 
preparation and the gelling agent’s chemical and structure features will dictate the 
vehicle’s interactions with the drug, the nanoparticles and the skin. Previous work on 
nanoparticle behaviour in topical formulations have concentrated on nanoparticle-vehicle 
interactions as in these published studies the drug is typically incorporated within the 
nanocarrier and not adsorbed to its surface like in the system where nanoparticles are 
used to disrupt molecular aggregation [15, 21, 22]. Therefore, in order to generate an 
effective nanoparticle-loaded gel that facilitates de-aggregation of a drug to enhance its 
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penetration into the skin using nanomaterials, further research is needed to determine the 
relationships between the drug aggregation, gel properties and nanoparticle interactions 
such that drug permeation into the skin from this novel preparation can be controlled. 
 
The aim of this study was to use nanoparticle-loaded hydroxyl methylcellulose 
(HPMC) and xanthan gum gels to probe how the drug, nanoparticle and formulation 
vehicle interactions influenced the delivery of an aggregated drug into the skin. 
Tetracaine was selected as a model drug as it has previously been shown to aggregate 
[23, 24]. It has a slow onset of action clinically [25] and nanoparticles with a negative 
surface charge have been shown to interact with the positively charged drug and modify 
its behaviour [11]. The experiments were conducted in pH 8 because Ametop, the 
commercially marketed gel, was formulated at pH 8 and the aggregation properties of 
tetracaine had been previously studied in this pH [5, 11]. Hydroxypropyl methycellulose 
(HPMC) was the chosen to produce the semi-solid formulation due its ability to form a 
gel with a large pore size, which minimises the potential for the gel structure to impart 
diffusional restriction on the drug [26]. A spray formulation was used to apply the HPMC 
system as this allowed the mixing of the nanoparticles and the drug only upon drug 
application, which avoided any physical instability issues that could reduce the 
homogeneity of dosing. The sprays were optimised in terms of evaporation kinetics, 
spray characterization, spray recovery and viscosity to ensure accurate dosing in the skin 
permeation studies. The HPMC system was compared with xanthan gum as it presented a 
negatively charged, tight gel and it allowed the direct use of the commercial Ametop 
formulation in the studies. Two drug application protocols were used to dose the drug to 
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the skin: infinite dose and finite dose studies because it was anticipated that the 
formulation viscosity, which may increase during finite dosing, could be influential in the 
delivery of the drug into the skin. Silica nanoparticles (NanoSiO2) were used to represent 
the nanoparticle surfaces with which the model drug tetracaine could interact. NanoSiO2 
were co-administered to the skin and no drug was encapsulated into the particles or 
adsorbed onto their surface prior to administration. The semi-solid dosage form’s 
macroviscosity were measured using traditional ‘cone and plate’ rheometry to have a 
better understanding of the interactions taking place in the system, i.e., between the drug, 
nanoparticle and formulation. 
 
Materials and Methods 
 
Materials 
 
HPMC powder (grade 65SH viscosity 400 cP and 50 cP, brand name Metolose) 
was provided by Shin-Etsu Chemical Ltd, Japan. Tetracaine free base (≥ 98%), 
hydrochloric acid, acetic acid and sodium acetate were purchased from Sigma Aldrich, 
UK. Commercially available Ametop gels were supplied by AAH Pharmaceuticals, UK. 
The Ametop gel contained tetracaine, sodium hydroxide, sodium methyl-p-
hydroxybenzoate, sodium propyl-p-hydroxybenzoate, monobasic potassium phosphate, 
xanthan gum, sodium chloride and purified water. Silica nanoparticles (NanoSiO2), with a 
diameter of 200 nm (Psi-0.2), were obtained from Kisker Biotech GmbH and Co., 
Germany. Ultrapure water (18.2 M) was used throughout this study unless stated 
 7 
otherwise. Phosphate-buffered saline tablets were supplied by Oxoid Limited, UK. 
Acetonitrile, methanol and water (high-performance liquid chromatography (HPLC 
grade) were obtained from Fisher Scientific International, UK. 
 
Formulation preparation 
 
The HPMC solutions were prepared by stirring HPMC powder slowly into pH 8 
water at 70 °C and allowing the system to hydrate for 24 h at 5 °C. The formulations 
were then transferred into 50 mL plastic spray bottles (Boots, UK). Three HPMC 
formulations were produced with polymer concentrations of 1% and 2% of Grade 65 
(viscosity 400 cP, 65SH400) and 3% of Grade 65 (viscosity 50 cP, 65SH50) because 
concentrations above these levels were unable to spray through the nozzle of the dosing 
system used to apply them to the skin in the permeation studies. The xanthan gum 
formulation used the commercial Ametop formulation and was used as supplied and did 
not need further characterisation. 
 
Evaporation kinetics 
 
Thirty actuations from each spray formulation (i.e. 1% 65SH400, 2% 65SH400, 
3% 65SH50) were applied to a tared weighing boat on an analytical balance and 
monitored for weight loss after application. Weight of the formulation (g) was plotted 
against time (min). The rate of solvent evaporation was calculated using a line of best fit. 
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The study lasted for 48 h to ensure the applied formulations were completely dry and no 
further weight loss occurred.  Triplicate experiments were performed. 
 
Spray characterisation 
 
The spray formulation placed at a distance of 5 cm vertically above a piece of 
filter paper and two shots was actuated from the spray canister holding the formulation 
onto the filter paper. The spray was allowed to dry and the film residue shape was 
outlined using a marker. The shortest diameter and the longest diameter of film residue 
shape were measured. The measurements were used to calculate the area covered by the 
product based on a perfect circle (Eqs, (1) and (2)) and the aspect ratio (AR, Eq. (3))). 
Triplicate measurements were performed for each formulation. 
 
Dmean =  
Dmin+ Dmax
2
 (1) 
Area =  π (
Dmean
2
)
2
   (2) 
AR =  
Dmin
Dmax
     (3) 
 
Spray recovery 
 
Ten actuations from the spray were applied to a tared weighing boat on an 
analytical balance and individually measured. The recovery was calculated as a 
percentage of the sum of the mass of the formulation in the container (Cfinal) and on the 
tared weighing boat (s) at the end of 10 actuations to the initial mass of formulation in the 
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container (Cinitial) for each sample, n=3 (Eq. 4). In addition, the amount of formulation 
recovered in the nozzle (nrecover) was measured by the subtraction of the initial mass of 
nozzle (ninitial) from the final mass of the nozzle (nfinal) (Eq. 5).  
 
Recovery (%) =  
Cfinal+s
Cinitial
 ×  100 % (4) 
nrecovery =  nfinal − ninitial  (5) 
 
 
Formulation rheology 
 
The rheological measurements were performed using CSL a cone and plate rheometer 
(Carri-med, USA) with plate diameter of 4.0 cm and cone angle of 1.5° at a 100 mm 
fixed gap. The test was performed over a 1-10 Hz frequency range at constant stress 
amplitude of 0.798 Pa (this stress was in the linear viscoelastic region) All the 
measurements were carried out at 20°C. Twenty data points were recorded for each 
rheogram and triplicates were performed for each formulation. 
 
Tetracaine permeation studies 
 
Fresh white adult porcine ears were obtained from a local abattoir (Evans and Sons, 
UK). Damaged ears were discarded. After cleaning with deionized water and wiping the 
residue with clean wipes, visible hairs were trimmed carefully. The preparation of 
epidermal porcine skin was carried out by heat separation [27]. Porcine skin was 
immersed and gently stirred in deionised water at 60C for 1 min. After removal from the 
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deionized water, the skin as put on a corkboard with the dermal side down and the 
epidermis was carefully separated from the dermis with tweezers. The separated 
epidermis was washed with deionized water and floated on filter paper (Whatman no. 1, 
UK) to act as a support before it is dried with clean wipes. The samples were wrapped in 
aluminium foil and stored at - 20C for a maximum of up to 1 month [28]. The samples 
were thawed before use.  
 
The permeation studies were carried out using upright individually calibrated Franz 
diffusion cells with an average of 2.1 ± 0.1 cm2 surface areas and 9.2 ± 0.5 mL receptor 
compartment volume. The porcine skin was cut, mounted and sealed with parafilm 
between two chambers of the glass diffusion cell with a 13 mm magnetic flea in the 
receiver chamber. The cell was inverted and filled with previously filtered and sonicated 
receiver fluid. Phosphate buffered saline (pH 7.4) was employed as a receiver fluid for 
the porcine epidermis permeation studies to mimic the skin environment. Sink conditions 
were maintained throughout the permeation studies (drug concentration in the receiver 
fluid does not exceed 10% of its saturated solubility). The saturated solubility of 
tetracaine was (6.29 ± 0.07) mM in pH 8 water and (7.16 ± 0.05) mM in phosphate 
buffered saline. The permeation studies were performed on a submergible magnetic 
stirrer plate in a pre-heated water bath set at 37°C to provide a membrane surface 
temperature of 32°C. After cell equilibration for 1 h, the cells were checked for leaks by 
inversion and visual inspection for back diffusion. The tetracaine test systems were 
prepared and adjusted to 8.0 using hydrochloric acid and equilibrated at 32°C unless 
stated otherwise. Solutions were stirred for at least 24 h and the pH rechecked prior to 
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analysis to ensure they were at equilibrium. The vehicle containing the nanoparticles was 
corrected to the necessary pH using hydrochloric acid prior to addition to the tetracaine 
solutions. The infinite dosing studies used 1 mL of tetracaine formulations (151 mM to 
ensure drug loading was matched across formulations), which were applied uniformly to 
the surface of the test membrane and the donor compartment was covered with a parafilm 
to minimise donor phase evaporation. In the infinite studies, an aqueous tetracaine 
solution of pH 8 was compared to a HPMC formulation (developed in the study) and the 
xanthan gum gel. None of the systems contained nanoparticles, as the initial objective 
was to understand the drug-vehicle interactions. The finite dosing tested the addition of 
nanoparticles on the formulations ability to deliver tetracaine in to the skin. The 
nanoparticles were added at a concentration of 50 mg/mL to the tetracaine formulations 
immediately prior to application to the skin to avoid any potential problems induced by 
chemical or physical instability. The finite dosing permeation study used 10 L, of 
xanthan gum gel or 3% HPMC formulation. The exact weight of the donor solution 
applied corresponded to 4.87 and 4.85 mg/cm2 respectively. To these two 151 mM drug-
loaded gels, an equal amount (10 L) of silica nanoparticles ( NanoSiO2 ) or water 
(control) were added to the formulation at the 0 h time point after correcting the 
suspension medium pH to 8. At predetermined time intervals, 1 mL aliquots were 
removed from the Franz cell receiver phases and replaced with fresh receiver fluid to 
keep the liquid volume in the receiver compartment constant. The collected receiver fluid 
samples were analysed by HPLC. A total of 5 replicates of each experiment were 
performed.  
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Cumulative amounts of drug (ng) penetrating the unit surface of the membrane area 
(cm2) were corrected for sample removal and plotted against time (h). The steady-state 
flux (J) was calculated from the slope of the linear portion of the curve (R2 ≥ 0.98), using 
at least 3 points with values above the assay limit of detection (LOQ). The permeability 
coefficient of tetracaine was calculated using equation 6 [29]: 
 
kp =  
J
Cv
                                                            (6)               
 
where kp represents the permeability coefficient of the permeant across the membrane, J 
is the flux and Cv is the concentration of the drug in the vehicle. The flux enhancement 
ratio (ER) of the different formulations was determined using the following equation:  
 
ER =  
J2
J1
                                             (7) 
 
where J1 and J2 are the steady-state transmembrane permeation rate of tetracaine from the 
tetracaine solutions and tetracaine-nanoparticle gel mixtures respectively. The 
accumulative mass of tetracaine permeated through the skin at 45 min was recorded, as 
this was the usual onset of action time for this agent. The permeation lag time was 
estimated from the X-axis intercept from the linear regression of the model applied to the 
permeation data in order to determine the flux. 
 
Tetracaine quantification 
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The quantification of tetracaine was performed using a reverse-phase HPLC 
system consisting of a pump with autosampler (Hewett-Packard series 1050, Agilent 
Technologies UK Ltd., UK) connected to a fluorescence detector (Shimadzu detector RF-
551, Shimadzu corp., Japan). The system was controlled via a computer with Chromeleon 
software (Dionex Corp., USA), which was also used to record and interpret the analytical 
data. The HPLC mobile phase comprised acetonitrile-methanol-acetate buffer (0.1 M) 
(25:25:50 (v/v), pH 5.1) set at a flow rate of 1.0 mL.min-1. Tetracaine was separated 
using a Luna 3 m C18(2) (150 X 4.6 mm) stationary phase (Phenomenex, UK) at room 
temperature with a 100 μL injection volume and the fluorescence detection at an 
excitation wavelength of 310 nm and an emission wavelength of 372 nm. The retention 
time for tetracaine was 4.2 min. The calibration curves were constructed on the basis of 
the peak area measurements using standard solutions of known tetracaine concentrations 
dissolved in an identical fluid as the receiver phase for the permeation studies (pH 4 
water). The assay was shown to be “fit for purpose” in terms of sensitivity (LOD – 4.08 
ng/mL, LOQ – 74 ng/mL, n=25), precision (6% CV), and linearity (R2 ≥ 0.99).  
 
Statistical Analysis 
 
All values were expressed as their mean ± standard deviation (SD). The statistical 
analysis of data was performed using the statistical package for social sciences, SPSS 
version 21, (IBM Corp., USA) with a significance level of 0.05. The normality (Sapiro-
Wilk) and homogeneity of variances (Levene’s test) of the data were assessed prior to 
statistical analysis. Permeation data were analysed statistically using one-way analysis of 
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variance (ANOVA) tests for normally distributed data and a non-parametric Kruskal-
Wallis tests for non-Gaussian distributed data. Post hoc comparisons of the means of 
individual groups were performed when appropriate using Dunnet’s test for normal 
distributed data and Games Howell test for non-Gaussian distributed data.  For all pair-
wise comparison of means, Student’s independent t-test or Mann-Whitney test was 
applied. Data were presented using OriginPro software (OriginPro version 8.6, OriginLab 
Corporation, US). 
 
Results 
 
Formulation optimization and characterization 
 
A high spray volume, a high percentage of spray recovery, a low amount of 
residual in the nozzle, a large spray deposit area and a moderately high viscosity were all 
thought to be desirable product characteristics for the spray systems. The rate of 
evaporation did not discriminate between the three formulations (Table 1, p>0.05, 0.2426 
± 0.0350 g/h), but the 2% 65SH400 was thought not to be ideal because it had the lowest 
spray actuation mass (66.7 ± 43.7 mg), lowest percentage spray recovery (99.72 ± 
0.09%), highest residual nozzle mass after spray actuation (66.0 ± 15.3 mg), lowest mean 
spray deposit diameter (2.4 ± 0.3 cm), lowest mean spray deposit area (4.5 ± 1.1 cm2) and 
highest viscosity (Fig. 1).  
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The 1% 65SH400 and 3% 65SH50 formulations were not significantly different 
(p>0.05) in terms of the amount of spray actuated (157.7 ± 14.1 mg) and the recovery 
from the spray container (99.83 ± 0.05%). However, 3% 65SH50 system was chosen for 
further investigation rather than 1% 65SH400 because, although it covered a relatively 
small area (5.9 ± 0.5 cm2), it showed appropriate viscosity to remain on the skin (Fig. 1) 
and it deposited 104-fold less residue on the spray nozzle (p<0.05). Furthermore, the 3% 
65SH50 gel was the most efficient in terms of ejecting the dose of the three spray 
formulations.  
 
Infinite permeation studies 
 
Infinite doses of tetracaine were used to understand the effect of vehicle 
composition on tetracaine permeation (Table 2, Fig. S2 for permeation profiles). 
According to manufacturer’s data, the xanthan gum gel consisted of saturated 
concentrations of tetracaine with sodium hydroxide, sodium methyl-o-hydroxybenzoate, 
sodium propyl-p-hydroxybenzoate, monoboasic potassium phosphate, xanthan gum, 
sodium chloride and purified water. The HPMC formulation consisted of saturated 
concentrations of tetracaine with 3% HPMC. No nanoparticles were added to these 
systems. There was no significant difference (p>0.05) in steady-state tetracaine 
permeation rate ((110.23 ± 40.93 µg/cm2/h) and lag time (9.15 ± 2.05 min) when infinite 
doses of tetracaine were delivered by xanthan gum gel and the HPMC formulation 
compared to a simple saturated tetracaine solution, i.e. with no formulation additives. 
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Finite permeation studies 
 
Finite studies were performed to study the permeation of tetracaine from the semi-
solid formulations using a dosing regimen that allowed formulation drying on the skin 
surface, which mimicked clinical application conditions (Table 3, Fig S3 and S4 for 
permeation profiles of xanthan gum and HPMC formulations respectively). Based on 
manufacturer’s data, the  NanoSiO2, which were added to the formulations, only consisted 
of amorphous silica and water. Thus, water acted as a control to mimic the drug dilution 
effects that were experienced upon addition of the nanoparticles to the formulations. 
Calculation of the lag time showed that the HPMC spray, with the added NanoSiO2 , had 
the shortest permeation lag time (2.02 ± 0.79 min). In addition, the tetracaine permeation 
rate (109.95 ± 28.63 µg/cm2/h) and the amount of tetracaine permeating at the 45 min 
time point (76.83 ± 18.92 µg) were the highest when the drug was formulated as the 
HPMC spray containing the NanoSiO2. The addition of water to the HPMC semi-solid 
formulation did not induce a significant change in tetracaine steady-state flux (30.51 ± 
12.16 µg/cm2/h) and accumulative mass permeating the skin at 45 min (21.99 ± 10.48 
µg), but it did induce a 1.7 times reduction in lag time from 7.09 ± 1.80 min to 3.97 ± 
1.07 min. (Table 3). Compared with the water control, the NanoSiO2  significantly 
enhanced (p<0.05) percutaneous tetracaine permeation by 3.6 fold when added to the 
HPMC formulation (Table 3). In addition, the NanoSiO2 significantly increased the 
accumulative mass at 45 min (m45min) by ca. 3 times and reduced the lag time (tlag) by ca. 
2-fold (Table 3).  
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In contrast to the HPMC formulation, the addition of water to the xanthan gum 
formulations significantly enhanced tetracaine permeation rates by 5-fold, increased 
accumulative mass by 10-fold and reduced lag time by 1.5 times (Table 3). Compared to 
the water control, the NanoSiO2 addition to the xanthan gum formulation increased the 
skin permeation by 2.7. However, of the two gels tested the HPMC formulation was 
superior, it significantly enhanced the tetracaine flux (46.99 ± 7.96 µg/cm2/h) by 40-fold, 
increased accumulative mass (31.13 ± 4.04 g) by 124-fold and reduced lag time (7.09 ± 
1.80 min) by 8-fold compared to the xanthan gum formulation.  
 
Rheology measurements 
 
The rheological characteristics of the semi-solid formulations were examined to 
try and further understand the observed differences in the tetracaine permeation profiles 
(Table 3). The xanthan gum formulations behaved as an elastic semi-solid (G’ > G’’) 
while the HPMC formulations behaved as a viscous liquid (G’’>G’). The addition of 
water in both formulations significantly decreased (p<0.05) G’ and G’’ values which 
indicated the macromolecular interactions in both systems were weekend. However, there 
were no significant changes (p>0.05) in rheological behaviour when the additions of 
water and NanoSiO2 to the gels were compared. 
 
Discussion 
 
Loading tetracaine into two semi-solid formulations, one containing HPMC and a 
second containing xanthan gum showed no important differences in terms of the drug 
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permeation when an infinite dose was applied to the surface of the skin. The data 
suggested that when the drug and excipient supply did not deplete on the surface of the 
skin the xanthan gum and the HPMC did not have a large effect on tetracaine delivery; 
the two formulations delivered the drug with a similar rate to the saturated solution. Both 
formulations presented the drug to the skin surface as an aggregate (the drug 
concentration in the formulation was above its measured critical aggregation 
concentration at pH 8 [5]) and the experimental data suggests that the drug aggregates 
moved through the gel at the same rates in the two different gel systems. These results 
accord with previous studies that have shown that gelling agents can be considered to be 
relatively inert [30, 31]. However, there have also been instances reported where HPMC 
has been actively involved in the process of drug delivery from the topical formulations. 
For example, in supersaturated conditions, HPMC has been shown to interact with a drug 
and act as an anti-nucleating agent [32-34]. The different effects of HPMC in semi-solid 
gels appear to be linked to the nature of the drug which the polymer delivers. In the case 
of tetracaine, it presents as positively charged aggregate which has strong self-association 
at pH 8 and this may minimise the drug’s interactions the macromolecules used to form 
topical gels [6]. As the gels showed no important differences, the nanomaterials were not 
added to infinite dosing studies. 
 
In the finite dosing studies the HPMC formulation showed a far superior 
penetration rate into the skin compared to the xanthan gum formulation, which did not 
align with the infinite dosing data. Differences between infinite and finite dosing 
protocols have been previously assigned to the increased sensitivity of the drug to its 
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environment when it begins to deplete in the formulation [35]. For example, in a study by 
Cross et al. [36], thickening agents were shown to retard drug penetration through the 
skin in infinite dose studies, but the opposite effect was observed in finite dose studies.  
 
As the gels showed a difference in the finite studies, the silica nanomaterials, 
which displayed a negative surface charge, were added to these systems to understand 
their effects. The nanomaterials were applied to the skin just after application of the drug-
loaded gels and these systems were compared to equivalent semi-solid formulations 
added to the skin with an aliquot of pH-adjusted water in order to account for the dilution 
effects that arose as a consequence of the dosing protocol. Both the xanthan gum and the 
HPMC gels showed enhanced drug permeation into the skin when mixed with the 
nanomaterials. Based on these results and the fact that the silica particles are known to be 
able to adsorb tetracaine [11], it was assumed that the drug permeation enhancement 
induced by the addition of the NanoSiO2was attributed to the breaking up of the tetracaine 
aggregates due to weak surface interactions between the negatively charged NanoSiO2 
surfaces and the positively charged tetracaine molecules. The fact that the HPMC + 
NanoSiO2 showed 100-fold increase in drug flux compared to the xanthan gum 
formulation that is employed commercially suggested that this could be a clinically 
important means to enhance tetracaine permeation into the skin.  
 
The addition of the silica particles did not change the rheological properties of the 
formulations and therefore, it seemed reasonable to suggest that the differences observed 
between the finite and infinite dosing studies should be assigned to the different influence 
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of the drug-vehicle agent interactions in the two types of experiments, rather than the 
nanoparticle-vehicle interactions because nanoparticle-vehicle interactions typically 
increase macromolecular entanglement and hence are translated into changes in the 
formulation rheological profile. For example, Moddaresi et al. [15] showed an increase in 
topical formulation viscoelasticity when lipid nanoparticles were added to hyaluronic 
acid vehicle. However, it made sense, that neither HPMC or xanthan gum would interact 
with the nanomaterials used in this work given that the HPMC gel was neutral and the 
xanthan gum was negatively charged and so they would presumably have limited 
interactions with the negatively charge nanomaterials [37].  
 
The xanthan gum gel appeared to be perturbed more than the HPMC formulation 
by the addition of an aliquot of water in the rheology studies and this provides some clues 
as to what effects the gels were having in the finite permeation studies. Xanthan gum is a 
branched, high molecular weight polysaccharide with acidic characteristics that forms a 
gel due xanthan chain dehydration [38]. Hydration of the xanthan gel by the addition of 
water would weaken the intermolecular links and reduce the diffusional restriction 
imparted upon the tetracaine molecules. In the finite studies, it is likely that solvent 
evaporation would cause the reverse effects, i.e., an increase in gel dehydration, which 
would strengthen the intermolecular interactions and impart a greater diffusional 
restriction on the drug. HPMC in contrast is a very weak gel [39] that forms as a 
consequence of the amphiphilic characteristics of macromolecule chains providing 
connections between hydrophobic and hydrophilic sites of the polymer. Although adding 
water to HPMC would reduce its viscosity, like other neutral polymers, it is likely that 
 21 
this gel would allow drug permeation to proceed independently of the gel viscosity 
because the mesh size of the gel is large and probably would not change much upon 
dilution [40, 41]. As a consequence, in the finite dosing study, the loss of water upon 
drying on the skin from the HPMC gel and the subsequent increase in viscosity would 
probably have a very limited effect on the drug permeation behaviour. The differences in 
the structures of the gels and their capability to interact with the drug to restrict its 
diffusion is also probably enhanced by the fact the HPMC gel is neutral, the xanthan gum 
gel is negatively charged at alkaline pHs and the drug is positively charged. Therefore, it 
is likely that tetracaine would display electrostatic interactions with xanthan gum gel and 
this would hinder the drug diffusion. 
 
Conclusions 
 
Through a combination of skin permeation studies and rheological assessment of 
nanoparticle-loaded HPMC and xanthan gum gels, this study shed more light on the 
complex relationship between the nanoparticle-vehicle and drug-vehicle interactions. The 
experimental data indicated that the interactions of the silica nanoparticles with the gel 
used to administer the drug to the skin were less important than the drug-vehicle 
interactions. Xanthan gum appeared to restrict the diffusion of the tetracaine due the 
dehydration of the formulation when applied to the surface of the skin which increased 
the gels intermolecular interactions and allowed the –ve charged gel interact with the +ve 
charged drug. In contrast, the HPMC gel formed a matrix that did not have a great impact 
on the drug permeation into the skin due to the weak gel that was formed and the inability 
for this system to display electrostatic interactions with the drug. Although it appeared 
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that the nanoparticles used in this work showed robust penetration enhancing 
characteristics when combined with tetracaine, i.e., they functioned to enhance the 
penetration of the drug into the skin from both gels, a weak, uncharged gel seemed to the 
be the optimal system to deliver this drug into the skin. 
 
 
 
 23 
References 
1. Potts, R.O. and R.H. Guy, Predicting skin permeability. Pharmaceutical research, 
1992. 9(5): p. 663-669. 
2. Wyn-Jones, E. and J. Gormally, Aggregation processes in solution. Vol. 26. 1983: 
Elsevier Science Ltd. 
3. Shore, P.A., B.B. Brodie, and C.A.M. Hogben, The gastric secretion of drugs: a 
pH partition hypothesis. Journal of Pharmacology and Experimental Therapeutics, 
1957. 119(3): p. 361-369. 
4. Potts, R.O. and R.H. Guy, A predictive algorithm for skin permeability: the effects 
of molecular size and hydrogen bond activity. Pharmaceutical research, 1995. 
12(11): p. 1628-1633. 
5. Cai , X.J., et al., Investigating the influence of drug aggregation on the 
percutaneous penetration rate of tetracaine when applying low doses of the agent 
topically to the skin. International Journal of Pharmaceutics, 2016. 502(1–2): p. 
10-17. 
6. Inacio, R., et al., Investigating how the attributes of self-associated drug 
complexes influence the passive transport of molecules through biological 
membranes. European Journal of Pharmaceutics and Biopharmaceutics, 2016. 
102: p. 214-222. 
7. Luengo, J., et al., Influence of nanoencapsulation on human skin transport of 
flufenamic acid. Skin Pharmacology and Physiology, 2006. 19(4): p. 190-197. 
8. Rouzes, C., et al., Influence of polymeric surfactants on the properties of drug-
loaded PLA nanospheres. Colloids and Surfaces B-Biointerfaces, 2003. 32(2): p. 
125-135. 
9. Alvarez-Roman, R., et al., Enhancement of topical delivery from biodegradable 
nanoparticles. Pharmaceutical Research, 2004. 21(10): p. 1818-1825. 
10. Fangueiro, J.F., et al., Thermodynamic behavior of lipid nanoparticles upon 
delivery of Vitamin E derivatives into the skin: in vitro studies. Journal of Thermal 
Analysis and Calorimetry, 2012. 108(1): p. 275-282. 
11. Cai , X.J., et al., Assessing the potential for drug-nanoparticle surface 
interactions to improve drug penetration into the skin. Mol Pharm, 2016. 
12. Baroli, B., et al., Penetration of metallic nanoparticles in human full-thickness 
skin. Journal of Investigative Dermatology, 2007. 127(7): p. 1701-1712. 
13. Ryman-Rasmussen, J.P., J.E. Riviere, and N.A. Monteiro-Riviere, Penetration of 
intact skin by quantum dots with diverse physicochemical properties. 
Toxicological Sciences, 2006. 91(1): p. 159-165. 
14. Wu, X., G.J. Price, and R.H. Guy, Disposition of nanoparticles and an associated 
lipophilic permeant following topical application to the skin. Mol Pharm, 2009. 
6(5): p. 1441-8. 
15. Moddaresi, M., et al., The role of vehicle–nanoparticle interactions in topical 
drug delivery. International journal of pharmaceutics, 2010. 400(1): p. 176-182. 
16. Watkinson, R.M., et al., Influence of Ethanol on the Solubility, Ionization and 
Permeation Characteristics of Ibuprofen in Silicone and Human Skin. Skin 
Pharmacology and Physiology, 2009. 22(1): p. 15-21. 
 24 
17. Welin-Berger, K., J.A.M. Neelissen, and B. Bergenstahl, The effect of theological 
behaviour of a topical anaesthetic formulation on the release and permeation 
rates of the active compound. European Journal of Pharmaceutical Sciences, 
2001. 13(3): p. 309-318. 
18. Radebaugh, G.W. and A.P. Simonelli, Phenomenological viscoelasticity of a 
heterogeneous pharmaceutical semisolid. Journal of Pharmaceutical Sciences, 
1983. 72(4): p. 415-422. 
19. Cross, S.E., et al., Probing the effect of vehicles on topical delivery: 
Understanding the basic relationship between solvent and solute penetration 
using silicone membranes. Pharmaceutical Research, 2001. 18(7): p. 999-1005. 
20. Dal Pozzo, A. and N. Pastori, Percutaneous absorption of parabens from cosmetic 
formulations. International Journal of Cosmetic Science, 1996. 18(2): p. 57-66. 
21. Hasanovic, A., et al., Chitosan-tripolyphosphate nanoparticles as a possible skin 
drug delivery system for aciclovir with enhanced stability. Journal of Pharmacy 
and Pharmacology, 2009. 61(12): p. 1609-1616. 
22. Batheja, P., et al., Topical drug delivery by a polymeric nanosphere gel: 
Formulation optimization and in vitro and in vivo skin distribution studies. 
Journal of Controlled Release, 2011. 149(2): p. 159-167. 
23. Schreier, S., S.V. Malheiros, and E. de Paula, Surface active drugs: self-
association and interaction with membranes and surfactants. Physicochemical 
and biological aspects. Biochimica et Biophysica Acta (BBA)-Biomembranes, 
2000. 1508(1): p. 210-234. 
24. Attwood, D., The mode of association of amphiphilic drugs in aqueous solution. 
Advances in colloid and interface science, 1995. 55: p. 271-303. 
25. Covino, B.G., Local anesthetic agents for peripheral nerve blocks. Regional-
Anaesthesie, 1980. 3(3): p. 33-37. 
26. Mohamed, F.A.A., et al., The effect of HPMC particle size on the drug release 
rate and the percolation threshold in extended-release mini-tablets. Drug 
Development and Industrial Pharmacy, 2015. 41(1): p. 70-78. 
27. Kligman, A.M. and E. Christophel, PREPARATION OF ISOLATED SHEETS OF 
HUMAN STRATUM CORNEUM. Archives of Dermatology, 1963. 88: p. 702-&. 
28. Harrison, S.M., B.W. Barry, and P.H. Dugard, EFFECTS OF FREEZING ON 
HUMAN-SKIN PERMEABILITY. Journal of Pharmacy and Pharmacology, 1984. 
36: p. 261-262. 
29. Williams, A., Transdermal and topical drug delivery: From theory to clinical 
practice. 2003: Pharmaceutical Press London. 
30. Kim, M.K., et al., Formulation of a reservoir-type testosterone transdermal 
delivery system. International Journal of Pharmaceutics, 2001. 219(1-2): p. 51-59. 
31. Charoo, N.A., et al., Improvement in bioavailability of transdermally applied 
flurbiprofen using tulsi (Ocimum sanctum) and turpentine oil. Colloids and 
Surfaces B-Biointerfaces, 2008. 65(2): p. 300-307. 
32. Raghavan, S.L., et al., Effect of cellulose polymers on supersaturation and in vitro 
membrane transport of hydrocortisone acetate. International Journal of 
Pharmaceutics, 2000. 193(2): p. 231-237. 
 25 
33. Iervolino, M., S.L. Raghavan, and J. Hadgraft, Membrane penetration 
enhancement of ibuprofen using supersaturation. International Journal of 
Pharmaceutics, 2000. 198(2): p. 229-238. 
34. Megrab, N.A., A.C. Williams, and B.W. Barry, Estradiol permeation through 
human skin and silastic membrane - effects of propylene-glycol and 
supersaturation. Journal of Controlled Release, 1995. 36(3): p. 277-294. 
35. Brown, D. and A. Ulsamer, Percutaneous penetration of hexachlorophene as 
related to receptor solutions. Food and cosmetics toxicology, 1975. 13(1): p. 81-
86. 
36. Cross, S.E., et al., Can increasing the viscosity of formulations be used to reduce 
the human skin penetration of the sunscreen oxybenzone? Journal of Investigative 
Dermatology, 2001. 117(1): p. 147-150. 
37. Bueno, V.B. and D.F.S. Petri, Xanthan hydrogel films: Molecular conformation, 
charge density and protein carriers. Carbohydrate polymers, 2014. 101: p. 897-
904. 
38. Geremia, R. and M. Rinaudo, Biosynthesis, structure, and physical properties of 
some bacterial polysaccharides. Polysaccharides: structural diversity and 
functional versatility. Vol. 15. 2005, New York: Marcel Dekker. 
39. Balaghi, S., Y. Edelby, and B. Senge. Evaluation of thermal gelation behavior of 
different cellulose ether polymers by rheology. in AIP Conference Proceedings 
1593. 2014. The Polymer Processing Society Nuremberg, Germany. 
40. Suh, H. and H.W. Jun, Physicochemical and release studies of naproxen in 
poloxamer gels. International Journal of Pharmaceutics, 1996. 129(1-2): p. 13-20. 
41. Gallagher, S.J. and C.M. Heard, Solvent content and macroviscosity effects on the 
in vitro transcutaneous delivery and skin distribution of ketoprofen from simple 
gel formulations. Skin Pharmacology and Physiology, 2005. 18(4): p. 186-194. 
 
  
 26 
 
 
 
Fig. 1 Storage modulus (G’, solid) and loss modulus (G’’, open) measured as a function 
of frequency (Hz) for various 1% 65SH400 (■), 2% 65SH400 (●) and 3% 65SH50 (▲) 
HPMC formulations. Data points represent mean ± standard deviation, n=3. 
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Fig. 2 Storage modulus (G’, top) and loss modulus (G’’, bottom) measured as a function 
of frequency (Hz) for the xanthan gum gel (■), xanthan gum gel + water (), xanthan 
gum gel + silica nanoparticles, NanoSiO2 (), HPMC gel (▼), HPMC gel + water (◇), 
HPMC gel + NanoSiO2 (). Data points represent mean ± standard deviation, n=3. The 
lines of the xanthan gum gel with and without the addition of water overlay each other. 
The same applies for the HPMC gel. 
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Table 1. Characteristics of various HPMC gels. Data represent mean ± standard 
deviation of 3 independent tetracaine samples. * Significant differences were observed 
based on one-way ANOVA test. 
 
1% 65SH400 2% 65SH400 3% 65SH50 
Evaporation rate (g/h) 0.24 ± 0.04 0.27 ± 0.03 0.25 ± 0.04 
Spray mass (mg) 157.7 ± 14.1  66.7 ± 43.7* 145.5 ± 27.5 
Spray recovery (%) 99.83 ± 0.05 99.72 ± 0.09* 99.92 ± 0.02 
Nozzle recovery (mg) 31.4 ± 18.2* 66.0 ± 15.3* 0.3 ± 0.1 
Dmean (cm) 3.5 ± 0.1* 2.4 ± 0.3 2.7 ± 0.1 
Area (cm2) 9.8 ± 0.6* 4.5 ± 1.1 5.9 ± 0.5 
Aspect ratio 1.0 ± 0.0 0.9 ± 0.1 0.7 ± 0.1 
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Table 2. Steady state flux and permeability constants, kp, accumulative mass at 45 
minutes, m45min, and lag time, tlag, of infinite dosages of tetracaine formulated in a 
xanthan gum gel and HPMC gel at pH 8 across porcine epidermis membrane. Data 
represent mean ± standard deviation of 3 independent tetracaine samples. 
 
 Flux  
(µg/cm2/h) 
kp  
(10-3 cm/h) 
m45min 
(µg) 
tlag 
(min) 
Saturated solution 110.23 ± 40.93 66.20 ± 24.58 64.5 ±  9.15 ± 2.05 
Xanthan gum gel 105.36 ± 21.97 63.27 ± 13.19 59.80 ± 9.31 10.10 ± 1.50 
HPMC gel 107.28 ± 28.31 64.43 ± 17.00 67.19 ± 18.21 8.79 ± 2.43 
   
 
  
 30 
Table 3. Steady state flux, flux enhancement ratio, ER, accumulative mass at 45 min, 
m45min, and lag time, tlag, of finite dosages of tetracaine loaded in xanthan gum and 
HPMC gels at pH 8 across porcine epidermis membrane. Data represent mean ± 
standard deviation of 3 independent tetracaine samples. * Significant differences, one-
way ANOVA. 
 
 
Flux  
(µg/cm2/h) 
ER m45min 
(µg) 
tlag 
(min) 
Xanthan gum  1.16 ± 0.14 - 0.25 ± 0.06 31.60 ± 3.00 
Xanthan gum + water 5.62 ± 2.25 4.71 ± 1.40* 2.53 ± 1.77* 20.20 ± 1.34* 
Xanthan gum + NanoSiO2 14.19 ± 2.27 12.86 ± 3.16
* 8.12 ± 1.21* 10.69 ± 1.98* 
HPMC 46.99 ± 7.96 - 31.13 ± 4.04 7.09 ± 1.80 
HPMC + water 30.51 ± 12.16 0.69 ± 0.35 21.99 ± 10.48 3.97 ± 1.07* 
HPMC + NanoSiO2  109.95 ± 28.63 2.48 ± 1.08
* 76.83 ± 18.92 * 2.02 ± 0.79* 
 
